Prudential Financial’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-104,501
| Closed | -$8.89M | – | 2540 |
|
|
2020
Q3 | $8.89M | Buy |
104,501
+8,900
| +9% | +$450K | 0.02% | 704 |
|
|
2020
Q2 | $3.39M | Sell |
95,601
-81,509
| -46% | -$2.38M | 0.01% | 1120 |
|
|
2020
Q1 | $2.39M | Sell |
177,110
-7,467
| -4% | -$126K | 0.01% | 1278 |
|
|
2019
Q4 | $3.9M | Sell |
184,577
-54,913
| -23% | -$969K | 0.01% | 1246 |
|
|
2019
Q3 | $3.4M | Buy |
239,490
+170,435
| +247% | +$2.51M | 0.01% | 1299 |
|
|
2019
Q2 | $958K | Buy |
69,055
+52,282
| +312% | +$787K | ﹤0.01% | 1889 |
|
|
2019
Q1 | $322K | Sell |
16,773
-169,710
| -91% | -$2.74M | ﹤0.01% | 2196 |
|
|
2018
Q4 | $2.79M | Buy |
186,483
+33,200
| +22% | +$659K | ﹤0.01% | 1352 |
|
|
2018
Q3 | $3.19M | Buy |
153,283
+13,230
| +9% | +$313K | ﹤0.01% | 1402 |
|
|
2018
Q2 | $3.31M | Buy |
140,053
+126,970
| +970% | +$2.55M | 0.01% | 1404 |
|
|
2018
Q1 | $191K | Buy |
13,083
+2,100
| +19% | +$34.3K | ﹤0.01% | 2261 |
|
|
2017
Q4 | $177K | Buy |
10,983
+100
| +0.9% | +$1.18K | ﹤0.01% | 2273 |
|
|
2017
Q3 | $152K | Buy |
10,883
+270
| +3% | +$2.69K | ﹤0.01% | 2275 |
|
|
2017
Q2 | $94K | Buy |
+10,613
| New | +$74.5K | ﹤0.01% | 2299 |
|
|
2014
Q3 | – | Sell |
-14,045
| Closed | -$51K | – | 2349 |
|
|
2014
Q2 | $51K | Sell |
14,045
-75,778
| -84% | -$278K | ﹤0.01% | 2385 |
|
|
2014
Q1 | $378K | Sell |
89,823
-24,700
| -22% | -$122K | ﹤0.01% | 2019 |
|
|
2013
Q4 | $527K | Buy |
+114,523
| New | +$510K | ﹤0.01% | 1953 |
|
Prudential Financial's IMMU Position: Q4 2020 in Review
Prudential Financial sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 104,501 shares — an estimated $8.89M sold.
Prudential Financial first reported a position in IMMU in Q4 2013 and held it in 17 quarters. The position peaked at $8.89M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Prudential Financial reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Prudential Financial sold 104,501 Immunomedics Inc shares in Q4 2020, an estimated $8.89M.
- Prudential Financial first reported a position in Immunomedics Inc in Q4 2013 and held it in 17 quarters.
- Prudential Financial's Immunomedics Inc position peaked at $8.89M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Prudential Financial's 13F filing for Q4 2020, filed 16 Feb 2021.